Investigating new treatments for Timothy syndrome through calcium channel modulation
Next generation calcium channel modulators
This study is looking at Timothy syndrome, a rare genetic condition that can cause serious heart issues, and aims to understand how different genetic changes affect heart health and treatment options, so we can find better ways to help people with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11045916 on NIH RePORTER |
What this research studies
This research focuses on Timothy syndrome, a rare genetic disorder caused by mutations in calcium channels that can lead to severe heart problems. By using advanced techniques like CRISPR to create stem cell models with various mutations, the research aims to better understand how these mutations affect heart function and drug response. The goal is to develop new treatment options that could improve outcomes for patients suffering from this condition. The study will explore the biophysical properties of calcium channels to inform the use of calcium channel blockers in therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Timothy syndrome or those who carry mutations in the CaV1.2 calcium channel.
Not a fit: Patients without Timothy syndrome or those whose conditions are unrelated to calcium channel dysfunction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new and effective treatments for patients with Timothy syndrome, potentially improving their quality of life and survival rates.
How similar studies have performed: Previous research has shown promise in using stem cell models to study genetic disorders, indicating that this approach could yield valuable insights for Timothy syndrome as well.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Dick, Ivy E — University of Maryland Baltimore
- Study coordinator: Dick, Ivy E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.